| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |